Preparation method of photosensitive wound damage repair hydrogel and hydrogel thereof
By using photosensitive hydrogels with recombinant human collagen, methacrylylated chitosan and zinc ions, the recurrence and healing problems of uterine adhesion treatment are solved, tissue repair and antibacterial effects are achieved, and it is suitable for endometrium. and repair of other tissue damage.
Patent Information
- Application Number
- CN202411241851.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-09-05
AI Technical Summary
The current treatment of uterine adhesions has a high recurrence rate, and drug treatment cannot effectively solve the problem of subsequent healing and repair, and may lead to wound adhesions and wound infection.
A photosensitive wound injury repair hydrogel containing recombinant human type I collagen, recombinant human type III collagen, methacrylylated chitosan and zinc ions, under ultraviolet or visible blue light Geling, used to repair endometrium and other tissue damage.
The hydrogel can be injected into tissues in a liquid state, photocrosslinking and solidifying, promotes wound healing, has antibacterial ability, prevents secondary infection, and is suitable for a variety of tissue repairs, including endometrial and skin repairs, significantly improving Treatment effect.
Smart Images

Figure CN118750660B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of materials, and in particular to a preparation method of a photosensitive wound damage repair hydrogel and the hydrogel. Background Art
[0002] One of the main causes of infertility in women of childbearing age is the damage to the endometrium due to congenital or acquired diseases, surgery, etc., which leads to a decrease in endometrial receptivity. Intrauterine adhesion (IUA), also known as Asherman's syndrome (AS), is usually caused by mechanical damage such as artificial abortion, curettage or infection, and manifests as damage to the basal layer of the endometrium, which in turn causes tissue adhesion and fibrosis, ultimately leading to decreased fertility.
[0003] The main clinical treatment method is hysteroscopic surgery, which is to separate the adhesion site through surgery. This method has a high recurrence rate and is prone to secondary injury. The treatment methods of drug infusion or oral medication also have obvious defects such as: the effective ingredients are easy to lose, which is only suitable for immediate injury treatment and cannot solve the subsequent healing and repair problems; it is also easy to cause late wound adhesion, wound infection, etc. Summary of the invention
[0004] In order to solve the above problems, the present invention provides a method for preparing a photosensitive wound damage repair hydrogel, characterized in that the hydrogel is a solution comprising: recombinant human type I collagen, recombinant human type III collagen, or a mixture of recombinant human type I collagen and recombinant human type III collagen, a solution of methacryloyl chitosan containing a photoinitiator and zinc ions; when the solution is subjected to a viscosity test at 37°C and a shear rate of 1 / s, the viscosity is 3000±3000*15% mPa·s to 15000±15000*15% mPa·s, preferably, the viscosity is 3000±3000*10% mPa·s to 15000±15000*10% mPa·s, and more preferably, the viscosity is 3000±3000*5% mPa·s to 15000±15000*5% mPa·s; the mass volume concentration of zinc ions is not greater than 0.2%, that is, the mass of zinc ions in 100 ml of solution is not greater than 0.2 g; when the solution is applied to the corresponding tissue, the tissue is irradiated externally with ultraviolet light or visible blue light, and the irradiation is stopped after the solution becomes a gel, thereby preparing the hydrogel.
[0005] Human collagen is divided into more than 28 types of collagen according to different tissue locations, physiological functions, and molecular structures. Among them, type I collagen and type III collagen are closely related to the skin damage repair process and repair quality. From the distribution point of view, type I collagen is mainly found in adult skin, tendons, and bone tissue; type III collagen is mainly found in infant skin or vascular endothelium and intestines. Type I and type III collagen in the human body maintain the normal tissue structure of the skin, constitute the extracellular matrix network structure, play a role in supporting organs and protecting the body, and are also related to cell attachment and cell migration. The balanced ratio of the two also determines the hardness and tenderness of the skin, as well as the degree of wound healing and scarring. Therefore, when recombinant human collagen is used in tissue repair, both type I and type III collagen can effectively promote repair and tissue regeneration.
[0006] In one embodiment, the zinc ion mass volume concentration is 0.05% to 0.2%.
[0007] In one embodiment, the photoinitiator is lithium phenyl-2,4,6-trimethylbenzoyl phosphite or (2-hydroxy-2-methyl-1-[4-(2-hydroxyethoxy)phenyl]-1-propanone).
[0008] In one embodiment, when the solution is tested for viscosity at 37° C. and a shear rate of 1 / s, the viscosity is 10025.85 mPa·s to 3163.85 mPa·s.
[0009] In one embodiment, when the mass volume concentration of the methacryloylated chitosan is 8%, that is, 100 ml of the solution includes 8 g of methacryloylated chitosan, when the mass volume concentration of recombinant human type I collagen, recombinant human type III collagen, or a mixture of recombinant human type I collagen and recombinant human type III collagen is 30%, that is, 100 ml of the solution includes 30 g of recombinant human type I collagen or recombinant human type III collagen, the volume ratio of the methacryloylated chitosan to the recombinant human type I collagen or recombinant human type III collagen is 3:1-1:1.
[0010] In one embodiment, the volume ratio of the methacryloylated chitosan to the recombinant human type I collagen or type III collagen is 1:1, and the mass volume concentration of zinc ions is 0.2%.
[0011] In one embodiment, a hydrogel for preventing and treating endometrial damage is provided, wherein the hydrogel is prepared by the above method.
[0012] In one embodiment, a hydrogel for preventing and treating intrauterine adhesions and thin endometrium is provided, wherein the hydrogel is prepared by the above method.
[0013] In one embodiment, a hydrogel for preventing and treating intrauterine adhesions and thin endometrium is provided, wherein the hydrogel comprises recombinant human type I collagen or type III collagen, methacryloyl chitosan containing a photoinitiator, and a solution containing zinc ions. When the solution is applied to a corresponding tissue, the tissue is externally irradiated with ultraviolet light or visible blue light, and the irradiation is stopped after the solution becomes a gel, thereby preparing the hydrogel; when the solution is subjected to a viscosity test at 37° C. and a shear rate of 1 / s, the viscosity is 3000±3000*15% mPa·s to 15000±15000*15% mPa·s, preferably, the viscosity is 3000±3000*10% mPa·s to 15000±15000*10% mPa·s, and more preferably, the viscosity is 3000±3000*5% mPa·s to 15000±15000*5% mPa·s; the mass volume concentration of zinc ions is not greater than 0.2%, that is, the mass of zinc ions in 100 ml of solution is not greater than 0.2 g.
[0014] In one embodiment, when the mass volume concentration of the methacryloyl chitosan is 8%, when the mass volume concentration of the recombinant human type I collagen or type III collagen is 30%, the volume ratio of the methacryloyl chitosan and the recombinant human type I collagen or type III collagen is 1:1, and the mass volume concentration of the zinc ion is 0.2%.
[0015] Tissue damage can occur in various organs or tissues of the human body, usually including external trauma, bacterial infection, surgical side effects, etc. If it is not treated promptly and effectively, it may lead to wound infection, slow healing, scar hyperplasia, and even necrosis. Based on methacrylated chitosan, recombinant human type I collagen or type III collagen, and zinc ions, the present invention proposes a preparation method of a photosensitive hydrogel with both antibacterial and tissue repair functions and its gel. The material can be injected into the corresponding tissue in its liquid state, and can be photocrosslinked and cured under ultraviolet or visible light to form a gel, firmly fit the wound, promote wound healing, and at the same time show bactericidal and antibacterial capabilities in the wound to prevent secondary infection. The present invention can be applied to a variety of tissue repair, antibacterial and fibrosis prevention, including visceral injury repair, endometrial repair, cartilage repair, superficial skin repair, etc., especially in the prevention and treatment of intrauterine adhesions and thin endometrium, it can achieve good therapeutic effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0017] Figure 1 The antibacterial effect diagram of the hydrogel of the present invention with different zinc ion loading ratios;
[0018] Figure 2 This is a diagram showing the repair effect of a hydrogel of the present invention on endometrial damage in rats. DETAILED DESCRIPTION
[0019] In order to enable those skilled in the art to better understand the technical solutions in the present application, the present invention will be further described below in conjunction with the following embodiments. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in the field without creative work should belong to the scope of protection of the present application. The present invention will be further described below in conjunction with the accompanying drawings and embodiments.
[0020] Example 1. Preparation of raw materials of the present invention
[0021] 1. Preparation of methacryloyl chitosan (CSMA)
[0022] Chitosan powder was added to 0.1 mol / L acetic acid solution with a mass volume fraction of 0.5%–5%, and stirred at room temperature until completely dissolved. The chitosan solution was placed in a 60 ℃ water bath, and methacrylic anhydride was added dropwise, wherein the weight ratio of chitosan to methacrylic anhydride was 1:2-1:3. After the addition was completed, the reaction was stirred at 60 ℃ for 6-12 h. After the reaction was completed, 0.5 mol / L NaOH solution was slowly added dropwise to the reaction solution to adjust the pH of the reaction solution to neutral. The neutral reactant solution was dialyzed in deionized water for 72 h, and the water was changed every 6 h. The dialyzed solution was frozen at -80 ℃ and vacuum freeze-dried for 72 h, and the freeze-dried powder product obtained was methacrylylated chitosan.
[0023] 2. Preparation of recombinant human collagen type I or type III (RC) solution
[0024] Dissolve recombinant human type I collagen or type III collagen powder in PBS buffer and stir at 37°C until completely dissolved.
[0025] 3. Preparation of zinc ion (Zn) solution
[0026] Dissolve zinc sulfate powder in PBS buffer and stir at room temperature until completely dissolved.
[0027] 4. Preparation of Methacrylylated Chitosan-Collagen + Zinc Ion Hydrogel (Hydrogel) Precursor Solution
[0028] Take methacryloyl chitosan powder, dissolve it in PBS buffer, add 0.25% photoinitiator at the same time, and stir at room temperature for 12 h until it is completely dissolved. Then add collagen solution and zinc ion solution, stir at 4 °C in the dark. Among them, the mass volume concentration of methacryloyl chitosan is 8% (w / v), the mass volume concentration of collagen is 30% (w / v), and the mass volume concentration of zinc ion solution is 10% (w / v).
[0029] 5. Hydrogel Preparation Method
[0030] When the methacryloyl chitosan-collagen + zinc ion hydrogel precursor solution is applied for injury repair, the solution is first applied to the corresponding tissue, and then the tissue is irradiated externally with ultraviolet light (365 nm) or visible blue light (405 nm), and the solution is stopped after it becomes a gel. At this time, the hydrogel can be highly fitted to the tissue to prevent tissue adhesion; at the same time, it can better play the repair role of various components and promote the repair and regeneration of damaged tissue. The material and application method are suitable for the repair of various wounds, especially irregularly shaped wounds, such as epidermal damage, endometrial damage, cartilage regeneration, vaginal mucosal damage, etc., and can prevent secondary infection and antibacterial at the injured site. The mixed solution can quickly change from liquid to gel under the irradiation of ultraviolet light (365 nm) or visible blue light (405 nm).
[0031] Example 2. Viscosity test of methacrylylated chitosan-collagen solution at different volume ratios
[0032] Methacryloyl chitosan (CSMA)-collagen (RC) solutions with different volume ratios were dripped onto the sample stage of the rheometer, and the viscosity was tested at 37 °C and a shear rate of 1 / s.
[0033] Table 1 Viscosity of CSMA:RC solutions with different ratios
[0034]
[0035] Viscosity test data show that changing the volume ratio of methacryloyl chitosan-collagen will directly affect the viscosity of the solution. When the ratio of CSMA:RC is greater than 3:1, the viscosity is lower than 3000 mPa·s, and its viscosity is small and fluidity is strong, which is not conducive to staying in the uterine cavity; when the ratio of CSMA:RC is less than 1:1, the viscosity is higher than 15000 mPa·s, and its viscosity is too high to achieve injectable type, and it is difficult to completely cover the damaged tissue and achieve the therapeutic effect. Therefore, it is believed that when CSMA:RC=1~3:1, the solution viscosity is suitable for use as a drug delivery platform in subsequent experiments.
[0036] Example 3 Experiment on cell compatibility and bactericidal effect of composite hydrogels loaded with different proportions of zinc ions
[0037] In a methacryloyl chitosan-collagen hydrogel precursor solution with a volume ratio of CSMA:RC=1:1, several different proportions of zinc sulfate solutions with a mass volume concentration of 10% are loaded to form several methacryloyl chitosan-collagen + zinc ion hydrogel precursor solutions with different compositions. The loading proportions of the zinc sulfate solution with a mass volume concentration of 10% are 0.1%, 0.5%, 1%, 2%, and 3%, that is, a total of 100 ml of the solution contains 0.1 ml, 0.5 ml, 1 ml, 2 ml, and 3 ml of the zinc sulfate solution with a mass volume concentration of 10%.
[0038] Each group of precursor solutions was injected into a six-well plate, and after ultraviolet irradiation sterilization for 30 minutes, methacrylylated chitosan-collagen + zinc ion hydrogels (respectively recorded as 0.1% hydrogel, 0.5% hydrogel, 1% hydrogel, 2% hydrogel, and 3% hydrogel) were formed. Each group of hydrogels and DMEM complete culture medium (DMEM basal medium, 10% fetal bovine serum and 1% double antibody, the double antibody is streptomycin and penicillin) were placed in a 50 ml sterile centrifuge tube to obtain a hydrogel sample with a concentration of 0.1 g / mL. The centrifuge tube containing the sample was placed in an incubator at 37 °C and 5% CO2 for 72 hours to obtain a hydrogel extract. Human endometrial stromal cells (HESCs) were cultured at 1×10 per well. 3 / 100μL cell suspension was inoculated in a 96-well plate and cultured in an incubator at 37℃ and 5% CO2 for 24 h. The culture medium was discarded and 200 μL of extract was added to each well to set up the experimental group. At the same time, a control group was set up to continue to culture with 200μL DMEM complete culture medium per well. Each group was cultured for 24 h, 48 h, and 72 h at the same time for observation, and 5 replicate wells were set up for each time point in each group. During the measurement, the old culture medium was discarded, 100 μL DMEM complete culture medium and 10μL CCK8 solution were added to each well, blown evenly, and incubated at 37℃ for 1.5 h, and the absorbance was measured at 450 nm using an enzyme reader.
[0039] The calculation formula of cell viability is:
[0040] Cell Viability(%)=(ODtest – Odblank) / (ODcontrol – Odblank)*100%
[0041] The calculated average cell survival rate is shown in the following table. According to the data in the table, except for the 3% hydrogel group, that is, when the zinc ion loading ratio is 3%, the cell survival rate is lower than 95% after 48 hours, which is considered unsuitable for normal cell growth and subsequent in vivo experiments. It is believed that when the zinc ion loading ratio is not more than 2%, the methacrylylated chitosan-collagen + zinc ion hydrogel has good cell compatibility, is suitable for use on wounds, and is conducive to wound healing.
[0042] Table 2 Effect of hydrogels with different zinc ion loading ratios on cell survival rate
[0043]
[0044] In the methacryloyl chitosan-collagen hydrogel precursor solution with a volume ratio of CSMA:RC=1:1, several zinc sulfate solutions in different proportions were loaded to form several methacryloyl chitosan-collagen + zinc ion hydrogel precursor solutions with different compositions. The loading ratio of zinc ion solution was 0.1%, 0.5%, 1%, 2% and 3%.
[0045] Each group of precursor solutions was injected into a six-well plate, cured by ultraviolet irradiation and sterilized for 30 min to form methacrylated chitosan-collagen + zinc ion hydrogels (respectively recorded as 0.1% hydrogel, 0.5% hydrogel, 1% hydrogel, and 2% hydrogel). Each group of hydrogels was mixed with Escherichia coli (E.Coli) and Staphylococcus aureus (S.aureus) bacterial liquid that had been shaken to logarithmic phase growth, with a ratio of hydrogel to bacterial liquid of 0.1 g / mL, placed in a 50 ml sterile centrifuge tube, and placed in a constant temperature shaker at 37°C and 200 rpm for 6 h. After diluting the bacterial liquid of each group 10,000 times, 100 μL was drawn and added to the LB solid culture medium, evenly coated, and placed in an incubator at 37°C and 5% CO2 for 12 h. The growth of the colonies in each group was observed and counted, and 3 replicates were made for each group.
[0046]
[0047] The colony growth and sterilization rate of each group are as follows Figure 1 As shown in Table 3, except for the 0.1% hydrogel group, the other groups all had significant reductions in colony growth. From the perspective of the sterilization rate, the sterilization rates of the 0.5% hydrogel, 1% hydrogel and 2% hydrogel groups reached more than 50%, which can effectively and quickly achieve antibacterial effects and have a good effect on preventing secondary infection during wound healing. Therefore, we believe that when the zinc ion loading ratio is greater than 0.5%, the composite hydrogel can have a good antibacterial effect.
[0048] Table 3 Effects of hydrogels with different zinc ion loading ratios on bacterial sterilization rate
[0049]
[0050] Example 4 Effects of different ratios of methacrylylated chitosan-collagen hydrogels on the repair ability of endometrial damage in rats
[0051] Methacryloyl chitosan-collagen hydrogel precursor solutions with volume ratios of CSMA:RC=1:1, CSMA:RC=2:1, and CSMA:RC=3:1 were prepared, and 2% zinc ions were loaded in each solution to form several methacryloyl chitosan-collagen + zinc ion hydrogel precursor solutions with different compositions, which were recorded as C1R1, C2R1, and C3R1.
[0052] The rat endometrial injury and repair experiment was established. Female SD rats aged 8 weeks, weighing about 250 g, and sexually mature were selected and cultured for one week. After the rats were anesthetized with isoflurane, the abdominal skin was prepared, the abdominal cavity was cut open, and the Y-shaped uterus was found. The upper and lower ends of the uterus were clamped with hemostatic clamps, and a 1 mL syringe was inserted into the rat uterus. 95% alcohol was injected until it was filled. After 60 seconds, the uterus was rinsed several times with normal saline. At this time, different concentrations of methacryloyl chitosan-collagen + zinc ion hydrogel precursor solutions (C1R1, C2R1, C3R1) were injected into the injured uterus, and then irradiated externally with ultraviolet light or blue light for about 60 seconds, which showed that it was in a gel state. After suturing and disinfection, the rats were kept and observed. At the same time, an alcohol injury control group (recorded as control) was set up. All rats were killed 7 days after surgery, and the uterine tissue was taken for photographs and fixed in 4% paraformaldehyde for 48 hours. After gradient dehydration with ethanol, paraffin embedding, and section staining, the rats were observed.
[0053] like Figure 2 The results showed that the uterus of the alcohol-injured control group showed obvious congestion, while the uteri of the C1R1, C2R1 and C3R1 groups had no obvious wounds. There was a very small amount of material remaining in the uterus, which was in a gel-like state. The H&E staining results showed that the rat uterine epithelium was lost after alcohol injury, the number of stromal cells was small, the arrangement was loose, and there was adhesion inside, and the repair effect was poor. The C1R1, C2R1 and C3R1 groups all had a certain degree of repair, with increased endometrial thickness, increased number of stromal cells, obvious glands, and complete coverage of the uterine cavity epithelium. Among them, the repair effect of the C1R1 group was more significant. The above results show that the C1R1 group, i.e., CSMA:RC=1:1, 2% zinc ion-loaded methacryloyl chitosan-collagen + zinc ion hydrogel, has good antibacterial ability and also has the ability to promote endometrial damage repair and wound healing.
[0054] It should be understood that the disclosed invention is not limited only to the specific method, scheme and material of description, because these all can change.It should also be understood that the terminology used herein is only for the purpose of describing specific embodiment scheme, rather than being intended to limit the scope of the present invention, and the scope of the present invention is only limited to the appended claims.
[0055] Those skilled in the art will also recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are also intended to be encompassed by the appended claims.
Claims
1. A solution for preparing a photosensitive wound damage repair hydrogel, characterized in that: The solution for preparing the hydrogel includes the following solution: recombinant human type I collagen, recombinant human type III collagen, or a mixture of recombinant human type I collagen and recombinant human type III collagen, a solution of methacryloyl chitosan containing a photoinitiator and zinc ions; when the solution is subjected to a viscosity test at 37°C and a shear rate of 1 / s, the viscosity is 3000 mPa·s to 15000 mPa·s; the mass volume concentration of zinc ions is 0.05% to 0.2%; when the solution is applied to the corresponding tissue, the tissue is irradiated externally with ultraviolet light or visible blue light, and the treatment is stopped when the solution becomes a gel, thereby preparing the hydrogel.
2. The solution according to claim 1, characterized in that The photoinitiator is phenyl-2,4,6-trimethylbenzoyl lithium phosphite or 2-hydroxy-2-methyl-1-[4-(2-hydroxyethoxy)phenyl]-1-propanone.
3. The solution according to claim 1, characterized in that When the solution is tested for viscosity at 37° C. and a shear rate of 1 / s, the viscosity is 10025.85 mPa·s to 3163.85 mPa·s.
4. The solution according to claim 1, characterized in that When the mass volume concentration of the methacryloyl chitosan is 8%, that is, 100 ml of the solution includes 8 g of methacryloyl chitosan; when the mass volume concentration of recombinant human type I collagen, recombinant human type III collagen, or a mixture of recombinant human type I collagen and recombinant human type III collagen is 30%, that is, 100 ml of the solution includes 30 g of recombinant human type I collagen or recombinant human type III collagen, the volume ratio of the methacryloyl chitosan to the recombinant human type I collagen or recombinant human type III collagen is 3:1-1:
1.
5. The solution according to claim 4, characterized in that The volume ratio of the methacryloyl chitosan to the recombinant human type I collagen or type III collagen is 1:1, and the mass volume concentration of the zinc ions is 0.2%.
6. A hydrogel for preventing and treating endometrial damage, characterized in that: When the solution described in any one of claims 1 to 5 is applied to the corresponding tissue, the tissue is irradiated externally with ultraviolet light or visible blue light, and the irradiation is stopped after the solution becomes gel-like, thereby preparing the hydrogel.
7. A hydrogel for preventing and treating intrauterine adhesions and thin endometrium, characterized in that: When the solution described in any one of claims 1 to 5 is applied to the corresponding tissue, the tissue is irradiated externally with ultraviolet light or visible blue light, and the irradiation is stopped after the solution becomes gel-like, thereby preparing the hydrogel.
8. A hydrogel for preventing and treating intrauterine adhesions and thin endometrium, characterized in that: The solution for preparing the hydrogel includes recombinant human type I collagen or type III collagen, methacryloyl chitosan containing a photoinitiator, and a solution containing zinc ions. When the solution is applied to the corresponding tissue, the tissue is irradiated externally with ultraviolet light or visible blue light, and the irradiation is stopped after the solution becomes a gel, thereby preparing the hydrogel; when the solution is tested for viscosity at 37° C. and a shear rate of 1 / s, the viscosity is 3000 mPa·s ~ 15000Pa·s; the mass volume concentration of the zinc ions is 0.05%~0.2%.
9. The hydrogel according to claim 8, characterized in that When the mass volume concentration of the methacryloyl chitosan is 8%, when the mass volume concentration of the recombinant human type I collagen or type III collagen is 30%, the volume ratio of the methacryloyl chitosan to the recombinant human type I collagen or type III collagen is 1:1, and the mass volume concentration of the zinc ion is 0.2%.
